PRKDC and neoplasm: A similar influence of sc-13 combined with another DNA-PKcs inhibitor, vx-984, was observed in multiple glioma cells, but the extent of the effects was different in other cancer cell lines, such as A549 and Huh-7 cells, reflecting promising targeting of FEN1/DNA-PKcs in tumor therapy (Fig. 6l).